Oscar Health, Inc.
NYSE:OSCR
21.44 (USD) • At close June 30, 2025
Overview | Financials
Numbers are in millions (except for per share data and ratios) USD.
| 2025 Q1 | 2024 Q4 | 2024 Q3 | 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 Q3 | 2023 Q2 | 2023 Q1 | 2022 Q4 | 2022 Q3 | 2022 Q2 | 2022 Q1 | 2021 Q4 | 2021 Q3 | 2021 Q2 | 2021 Q1 | 2020 Q4 | 2020 Q3 | 2020 Q2 | 2020 Q1 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue
| 3,046.263 | 2,392.813 | 2,423.482 | 2,219.341 | 2,142.839 | 1,431.632 | 1,439.991 | 1,522.124 | 1,469.685 | 1,037.66 | 1,018.513 | 1,058.335 | 1,011.076 | 520.327 | 462.193 | 549.747 | 388.694 | 187.629 | 133.309 | 145.574 | 123.129 |
| Cost of Revenue
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Gross Profit
| 3,046.263 | 2,392.813 | 2,423.482 | 2,219.341 | 2,142.839 | 1,431.632 | 1,439.991 | 1,522.124 | 1,469.685 | 1,037.66 | 1,018.513 | 1,058.335 | 1,011.076 | 520.327 | 462.193 | 549.747 | 388.694 | 187.629 | 133.309 | 145.574 | 123.129 |
| Gross Profit Ratio
| 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 |
| Reseach & Development Expenses
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| General & Administrative Expenses
| 482.759 | 466.58 | 459.522 | 435.144 | 394.696 | 85.61 | 325.82 | 337.833 | 396.984 | 75.808 | 78.557 | 80.754 | 74.664 | 89.838 | 60.003 | 51.166 | 64.572 | 62.276 | 36.546 | 35.994 | 31.839 |
| Selling & Marketing Expenses
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| SG&A
| 482.759 | 466.58 | 459.522 | 435.144 | 394.696 | 85.61 | 325.82 | 337.833 | 396.984 | 75.808 | 78.557 | 80.754 | 74.664 | 89.838 | 60.003 | 51.166 | 64.572 | 62.276 | 36.546 | 35.994 | 31.839 |
| Other Expenses
| 2,275.293 | 2,079.922 | 2,016.272 | 1,723.248 | 1,569.665 | 1,496.666 | 1,178.959 | 1,198.552 | 1,110.308 | 1,189.127 | 1,135.118 | 1,089.416 | 1,012.215 | 628.842 | 614.268 | 571.315 | 412.038 | 315.704 | 176.893 | 148.931 | 187.238 |
| Operating Expenses
| 2,758.052 | 2,546.502 | 2,475.794 | 2,158.392 | 1,964.361 | 1,582.276 | 1,504.779 | 1,536.385 | 1,507.292 | 1,264.935 | 1,213.675 | 1,170.17 | 1,086.879 | 718.68 | 674.271 | 622.481 | 476.61 | 377.98 | 213.439 | 184.925 | 219.077 |
| Operating Income
| 288.211 | -153.689 | -52.312 | 60.949 | 178.478 | -150.644 | -64.788 | -14.261 | -37.607 | -227.275 | -195.162 | -111.835 | -75.803 | -198.353 | -212.078 | -72.734 | -87.916 | -190.351 | -80.13 | -39.351 | -95.948 |
| Operating Income Ratio
| 0.095 | -0.064 | -0.022 | 0.027 | 0.083 | -0.105 | -0.045 | -0.009 | -0.026 | -0.219 | -0.192 | -0.106 | -0.075 | -0.381 | -0.459 | -0.132 | -0.226 | -1.015 | -0.601 | -0.27 | -0.779 |
| Total Other Income Expenses Net
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Income Before Tax
| 288.211 | -153.689 | -52.312 | 60.949 | 178.478 | -150.644 | -64.788 | -14.261 | -37.607 | -227.275 | -195.162 | -111.835 | -75.803 | -198.353 | -212.078 | -72.734 | -87.916 | -190.351 | -80.13 | -39.351 | -95.948 |
| Income Before Tax Ratio
| 0.095 | -0.064 | -0.022 | 0.027 | 0.083 | -0.105 | -0.045 | -0.009 | -0.026 | -0.219 | -0.192 | -0.106 | -0.075 | -0.381 | -0.459 | -0.132 | -0.226 | -1.015 | -0.601 | -0.27 | -0.779 |
| Income Tax Expense
| 12.705 | -0.404 | 2.076 | 4.637 | 0.996 | -0.806 | 0.915 | 1.164 | 2.021 | -0.715 | -1.615 | 0.29 | 1.517 | -0.111 | -0.597 | 0.589 | 0.965 | -0.481 | -0.998 | 1.593 | 0.931 |
| Net Income
| 275.271 | -153.547 | -54.596 | 56.207 | 177.368 | -150.03 | -65.398 | -15.528 | -39.772 | -226.046 | -192.913 | -112.164 | -75.152 | -199.422 | -211.481 | -73.323 | -88.881 | -189.87 | -79.132 | -40.944 | -96.879 |
| Net Income Ratio
| 0.09 | -0.064 | -0.023 | 0.025 | 0.083 | -0.105 | -0.045 | -0.01 | -0.027 | -0.218 | -0.189 | -0.106 | -0.074 | -0.383 | -0.458 | -0.133 | -0.229 | -1.012 | -0.594 | -0.281 | -0.787 |
| EPS
| 1.1 | -0.62 | -0.22 | 0.24 | 0.77 | -0.66 | -0.29 | -0.071 | -0.18 | -1.05 | -0.91 | -0.53 | -0.37 | -0.95 | -1.02 | -0.35 | -0.98 | -0.96 | -2.7 | -1.4 | -3.31 |
| EPS Diluted
| 0.92 | -0.62 | -0.22 | 0.18 | 0.6 | -0.66 | -0.29 | -0.071 | -0.18 | -1.05 | -0.91 | -0.53 | -0.37 | -0.95 | -1.02 | -0.35 | -0.98 | -0.93 | -0.39 | -0.2 | -0.48 |
| EBITDA
| 300.935 | -138.43 | -38.997 | 74.541 | 192.191 | -136.685 | -49.467 | 0.681 | -26.532 | -217.405 | -184.978 | -102.003 | -67.783 | -193.986 | -208.035 | -68.919 | -80.816 | -183.542 | -77.205 | -36.83 | -93.404 |
| EBITDA Ratio
| 0.099 | -0.058 | -0.016 | 0.034 | 0.09 | -0.095 | -0.034 | 0 | -0.018 | -0.21 | -0.182 | -0.096 | -0.067 | -0.373 | -0.45 | -0.125 | -0.208 | -0.978 | -0.579 | -0.253 | -0.759 |